Clinical Trial Update: S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial update examining gemtuzumab in combination with chemotherapy for previously untreated acute promyelocytic leukemia; results posted after completio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Promyelocytic Leukemia

Drugs mentioned

• Gemtuzumab (gemtuzumab ozogamicin)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2017-12-22